Antimicrobial Prophylaxis during Hirudo medicinalis Therapy: A Multicenter Study

Abstract

Background Medicinal leeches (Hirudo medicinalis) are indicated for salvage of tissue flaps, grafts, or replants when venous congestion threatens tissue viability. The purpose of this study was to evaluate the efficacy of prophylactic antimicrobial agents in patients who received medicinal leech therapy.

Materials and Methods A multicenter retrospective cohort study of all adult patients between January 1, 2010, and February 28, 2013, who received medicinal leech therapy was conducted.

Results Antimicrobial prophylaxis was documented in 54 (91.5%) of the included patients, ciprofloxacin, trimethoprim-sulfamethoxazole, piperacillin-tazobactam, and ceftriaxone in 33 (61.1%), 18 (33.3%), 2 (3.7%), and 2 (3.7%) patients, respectively. Surgical site infection (SSI) was found in seven (11.9%) patients, all of whom received antimicrobial prophylaxis. Aeromonas spp. was isolated in four infections, and all isolates were resistant to the chosen prophylactic agent. The SSI incidence was similar between antimicrobial prophylaxis agents.

Conclusion Trimethoprim-sulfamethoxazole and ciprofloxacin appear equally effective at preventing leech-associated infections.

Keywords

leech - antimicrobial prophylaxis - surgical site infection

• References

• 1 Schnabl SM, Kunz C, Unglaub F, Polykandriotis E, Horch RE, Dragu A. Acute postoperative infection with Aeromonas hydrophila after using medical leeches for treatment of venous congestion. Arch Orthop Trauma Surg 2010; 130 (10) 1323-1328
• 2 Whitaker IS, Oboumarzouk O, Rozen WM , et al. The efficacy of medicinal leeches in plastic and reconstructive surgery: a systematic review of 277 reported clinical cases. Microsurgery 2012; 32 (3) 240-250
• 3 Whitaker IS, Josty IC, Hawkins S , et al. Medicinal leeches and the microsurgeon: a four-year study, clinical series and risk benefit review. Microsurgery 2011; 31 (4) 281-287
• 4 de Chalain TM. Exploring the use of the medicinal leech: a clinical risk-benefit analysis. J Reconstr Microsurg 1996; 12 (3) 165-172
• 5 Sartor C, Limouzin-Perotti F, Legré R , et al. Nosocomial Infections with Aeromonas hydrophila from Leeches. Clin Infect Dis 2002; 35 (1) E1-E5
• 6 Bauters TG, Buyle FM, Verschraegen G , et al. Infection risk related to the use of medicinal leeches. Pharm World Sci 2007; 29 (3) 122-125
• 7 Bibbo C, Fritsche T, Stemper M, Hall M. Flap infection associated with medicinal leeches in reconstructive surgery: two new drug-resistant organisms. J Reconstr Microsurg 2013; 29 (7) 457-460
• 8 Patel KM, Svestka M, Sinkin J, Ruff IV P. Ciprofloxacin-resistant Aeromonas hydrophila infection following leech therapy: a case report and review of the literature. J Plast Reconstr Aesthet Surg 2013; 66 (1) e20-e22
• 9 Elyassi AR, Terres J, Rowshan HH. Medicinal leech therapy on head and neck patients: a review of literature and proposed protocol. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 116 (3) e167-e172
• 10 Whitaker IS, Izadi D, Oliver DW, Monteath G, Butler PE. Hirudo Medicinalis and the plastic surgeon. Br J Plast Surg 2004; 57 (4) 348-353